- Over 50gw of solar installations in india are protected by socomec pv disconnect switches, driving sustainable growth
- Draft Karnataka Space Tech policy launched at Bengaluru Tech Summit
- एसर ने अहमदाबाद में अपने पहले मेगा स्टोर एसर प्लाज़ा की शुरूआत की
- Acer Opens Its First Mega Store, Acer Plaza, in Ahmedabad
- Few blockbusters in the last four or five years have been the worst films: Filmmaker R. Balki
Kansai Nerolac Paints Ltd Announces Q1 Results FY 2021-2022
Mumbai, July 30, 2021: Kansai Nerolac Paints Limited (KNPL), one of the leading Paint companies in India, today at the Board meeting announced its unaudited results for the first quarter of financial year 2021-22. For the quarter, the company declared Net revenue of Rs. 1301.2 Crores, a growth of 117.6 % over the corresponding quarter of the previous year.
EBIDTA was at Rs. 187.1 Crores, a growth of 132.4 % over the same quarter of the previous year. PAT was at Rs 118.7 Crores, a growth of 177.8 % over the same quarter of the previous year.
Commenting on the results, Mr. H. M. Bharuka, Vice Chairman and Managing Director, Kansai Nerolac Paints Ltd said, “The quarter began on an extremely positive note. With the announcement of the lockdown across several states towards the end of April, demand was once again affected across both Decorative and Industrial in April and May. In June there was a revival in Decorative demand once the restrictions eased. Industrial demand continued to be impacted.
Continuing the trend of earlier quarters, raw material prices further hardened resulting in extremely high inflation coupled with tightness in supplies. Forex markets continued to be volatile. The company has partly increased prices in Decorative. In Industrial, also the company has increased prices and is making sustained effort to obtain price increases to offset the impact of inflation.
The company focused on selling a better product mix. It continued with the aggressive cost control program and judicious management of overheads. It is because of these steps that the drop in EBITDA has been contained.
Looking forward, with the vaccination program underway and a forecast of a good monsoon, demand should recover. Company would be aggressive in seeking price increases.